These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8759879)

  • 21. Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.
    Hartmann L; Biggerstaff JS; Chapman DB; Scott JM; Johnson KR; Ghirardelli KM; Fritschle WK; Martinez DL; Bennington RK; de Baca ME; Wells DA; Loken MR; Zehentner BK
    Am J Clin Pathol; 2011 Nov; 136(5):712-20. PubMed ID: 22031309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.
    Ng MH; Wong N; Lau TT; Tsang KS; Cheng SH; Chan NP; Tang SH; Lei KI; Leung Y
    Oncol Rep; 2003; 10(3):587-91. PubMed ID: 12684628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
    Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
    Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of chromosome abnormalities using cytoplasmic immunoglobulin staining and FISH in myeloma.
    Mercer BR; Rayeroux KC
    Methods Mol Biol; 2011; 730():159-71. PubMed ID: 21431641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Frequency and prognostic value of chromosome abnormalities in multiple myeloma].
    Kurahashi S; Sawamoto A; Sugimoto T; Narimatsu H; Iwasaki T; Adachi T; Suzuki H; Hayakawa F; Sugiura I
    Rinsho Ketsueki; 2007 Nov; 48(11):1455-61. PubMed ID: 18080502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of chromosomal aberrations in multiple myeloma with fluorescence in situ hybridization].
    Cao P; Chen F; Cheng Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 37(10):983-9. PubMed ID: 23117450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.
    Klein B; Seckinger A; Moehler T; Hose D
    Recent Results Cancer Res; 2011; 183():39-86. PubMed ID: 21509680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescent in situ hybridization studies in multiple myeloma.
    Yuregir OO; Sahin FI; Yilmaz Z; Kizilkilic E; Karakus S; Ozdogu H
    Hematology; 2009 Apr; 14(2):90-4. PubMed ID: 19298720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic and biological characterization of two new human plasma cell lines.
    Brox LW; Belch A; Pollock E; He XX; De Braekeleer M; Lin CC
    Cancer Genet Cytogenet; 1987 Jul; 27(1):135-44. PubMed ID: 3472643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
    Nilsson T; Lenhoff S; Rylander L; Höglund M; Turesson I; Mitelman F; Westin J; Johansson B
    Br J Haematol; 2004 Aug; 126(4):487-94. PubMed ID: 15287940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of peripheral blood cells in multiple myeloma: chromosome changes are the rule within circulating plasma cells but not within B lymphocytes.
    Zandecki M; Bernardi F; Genevieve F; Laï JL; Preudhomme C; Flactif M; Cosson A; Bauters F; Facon T
    Leukemia; 1997 Jul; 11(7):1034-9. PubMed ID: 9204987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
    Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
    J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fluorescence in situ hybridization on bone marrow smear in the detection of cytogenetic aberrations of multiple myeloma].
    Wang XW; Li JY; Chen LJ; Qian SX; Hong M; Qiao C; Zhang JF; Xu W; Lu H; Xu JR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1230-3. PubMed ID: 19840456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metaphase chromosomes of human multiple myeloma cells of line U-266: karyotype and morpho-functional characteristics of nucleolar organizer regions].
    Turilova VI; Pendina AA; Smirnova TD
    Tsitologiia; 2003; 45(6):606-13. PubMed ID: 14521092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myeloma.
    An G; Li Z; Tai YT; Acharya C; Li Q; Qin X; Yi S; Xu Y; Feng X; Li C; Zhao J; Shi L; Zang M; Deng S; Sui W; Hao M; Zou D; Zhao Y; Qi J; Cheng T; Ru K; Wang J; Anderson KC; Qiu L
    Clin Cancer Res; 2015 May; 21(9):2148-56. PubMed ID: 25652456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome 1 abnormalities in multiple myeloma.
    Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by cIg FISH.
    White JS; Zordan A; Batzios C; Campbell LJ
    Cancer Genet; 2012 Dec; 205(12):644-52. PubMed ID: 23200818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of characteristic and prognostic values of chromosome 1p abnormality by multi-gene fluorescence in situ hybridization in multiple myeloma.
    Li F; Hu L; Xu Y; Li Z; Yi S; Gu Z; Li C; Hao M; Ru K; Zhan F; Zetterberg A; Yuan W; Cheng T; Qiu L
    Leukemia; 2016 May; 30(5):1197-201. PubMed ID: 26460211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.